Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 03/03/2021.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | GLUCOSALINE INFO | GLUCOSE MONOHYDRATE+CHLORURE DE SODIUM | 5/0.45 | Solution injectable pour perfu | Poche de 500 ml | INFOMED Pharma | V | N | 03/02/2021 |
2 | GLUCOSALINE INFO | GLUCOSE MONOHYDRATE+CHLORURE DE SODIUM | 5/0.45 | Solution injectable pour perfu | Poche de 250 ml | INFOMED Pharma | V | N | 03/02/2021 |
3 | LEVOCETIRIZINE SIMED | LEVOCETIRIZINE | 0.5mg/ml | Solution buvable | FL/200ML | SIMED | E | N | 03/02/2021 |
4 | LEVOCETIRIZINE SIMED | LEVOCETIRIZINE | 5mg/ml | Solution buvable | FL/15ML | SIMED | E | N | 03/02/2021 |
5 | OLMECARD PLUS | OLMESARTAN MEDOXOMIL+HYDROCHLORTHIAZIDE | 20mg/25mg | Comprimé pelliculé | B/30 | THERA | E | N | 03/02/2021 |
6 | OLMECARD PLUS | OLMESARTAN MEDOXOMIL+HYDROCHLORTHIAZIDE | 20mg/12.5mg | Comprimé pelliculé | B/30 | THERA | E | N | 03/02/2021 |
7 | OLMECARD PLUS | OLMESARTAN MEDOXOMIL+HYDROCHLORTHIAZIDE | 40mg/25mg | Comprimé pelliculé | B/30 | THERA | E | N | 03/02/2021 |
8 | OLMECARD PLUS | OLMESARTAN MEDOXOMIL+HYDROCHLORTHIAZIDE | 40mg/12.5mg | Comprimé pelliculé | B/30 | THERA | E | N | 03/02/2021 |
9 | TORENTAL | PENTOXYFYLLINE | 400 mg | Comprimé à libération prolongé | B/20 | SANOFI AVENTIS PHARMA TUNISIE | I | N | 03/02/2021 |
10 | DAONIL | GLIBENCLAMIDE | 5 mg | COMPRIMÉ SÉCABLE | B/20 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 03/02/2021 |
11 | DAONIL | GLIBENCLAMIDE | 5 MG | COMPRIMÉ SÉCABLE | B/100 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 03/02/2021 |
12 | FLAGYL | METRONIDAZOLE | 250 mg | COMPRIMÉ PELLICULÉ | B/20 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 03/02/2021 |
13 | LASILIX | FUROSEMIDE | 40 mg | COMPRIMÉ SÉCABLE | B/20 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 03/02/2021 |
14 | XABAN | RIVAROXABAN | 15 mg | COMPRIMÉ PELLICULÉ | B/28 | TERIAK | E | N | 05/02/2021 |
15 | BIFOR5 | TADALAFIL | 5 mg | COMPRIMÉ PELLICULÉ | B/30 | PHILADELPHIA PHARMA | C | N | 12/02/2021 |
16 | CITOM | CLOMIFENE CITRATE | 50mg | COMPRIMÉ | B/5 | LINO PHARMA | E | N | 12/02/2021 |
17 | CITOM | CLOMIFENE CITRATE | 50mg | COMPRIMÉ | B/10 | LINO PHARMA | E | N | 12/02/2021 |
18 | ESOMAX | EZOMEPRAZOLE | 20mg | GELULE GASTRORESISTANTE | B/07 | DAR ESSAYDALI | E | N | 12/02/2021 |
19 | ESOMAX | EZOMEPRAZOLE | 20mg | GELULE GASTRORESISTANTE | B/14 | DAR ESSAYDALI | E | N | 12/02/2021 |
20 | ESOMAX | EZOMEPRAZOLE | 20mg | GELULE GASTRORESISTANTE | B/28 | DAR ESSAYDALI | E | N | 12/02/2021 |
21 | ESOMAX | EZOMEPRAZOLE | 40mg | GELULE GASTRORESISTANTE | B/07 | DAR ESSAYDALI | E | N | 12/02/2021 |
22 | ESOMAX | EZOMEPRAZOLE | 40mg | GELULE GASTRORESISTANTE | B/14 | DAR ESSAYDALI | E | N | 12/02/2021 |
23 | ESOMAX | EZOMEPRAZOLE | 40mg | GELULE GASTRORESISTANTE | B/28 | DAR ESSAYDALI | E | N | 12/02/2021 |
24 | OCTREOTIDE NEAPOLIS | OCTREOTIDE ACETATE | 0,1mg | solution injectable | B/10FL | NEAPOLIS | E | N | 12/02/2021 |
25 | RGEO | EZOMEPRAZOLE | 20mg | GELULE | B/07 | SAIPH | E | N | 12/02/2021 |
26 | RGEO | EZOMEPRAZOLE | 20mg | GELULE | B/14 | SAIPH | E | N | 12/02/2021 |
27 | VILDAMET | Vildagliptine Metformine | 50/1000mg | Comprimé | B/60 | Philadelphia | E | N | 12/02/2021 |
28 | PRIMALAN | Méquitazine | 5 mg | comprimé sécable | B/14 |
Pierre Fabre | E | N | ___ |
29 | PRIMALAN Fort | Méquitazine | 10 mg | comprimé sécable | B/14 |
Pierre Fabre | E | N | ___ |
30 | VITAPRED 5 | PREDNISOLONE | 5 mg | Comprimé orodispersible | B/30 | TAHA PHARMA | E | N | |
31 | COLTRAMYL | THIOCOLCHICOSIDE | 4 MG | Comprimé sécable | B/12 | SANOFI AVENTIS PHARMA TUNISIE | I | N | 16/02/2021 |
32 | ANDOTER | ACETATE DE CYPROTERONE | 50 mg | comprimé sécables | B/20 | NEWIX- TUNISIE | V | N | 22/02/2021 |
33 | ANDOTER | ACETATE DE CYPROTERONE | 50 mg | comprimé sécables | B/60 | NEWIX- TUNISIE | V | N | 22/02/2021 |
34 | ANDOTER | ACETATE DE CYPROTERONE | 100 mg | comprimé sécables | B/20 | NEWIX- TUNISIE | V | N | 22/02/2021 |
35 | ANDOTER | ACETATE DE CYPROTERONE | 100 mg | comprimé sécables | B/60 | NEWIX- TUNISIE | V | N | 22/02/2021 |
36 | ANGIOPRINE | ACIDE ACETYLSALICYLIQUE | 75 mg | comprimé gstro-résistant | B/30 | THERA | E | N | 22/02/2021 |
37 | GLINORM | REPAGLINIDE | 2 mg | comprimé pelliculé | B/30 | SAIPH | E | N | 22/02/2021 |
38 | GLINORM | REPAGLINIDE | 1 mg | comprimé pelliculé | B/30 | SAIPH | E | N | 22/02/2021 |
39 | TRIPAKINE | VALPROATE DE SODIUM/ACIDE VALPROIQUE | 500 mg | comprimé pelliculé | B/30 | SAIPH | N | 22/02/2021 | |
40 | NEURYL | PREGABALINE | 150 mg | Gélule | B/30 | ADWYA | V | N | 22/02/2021 |
41 | NEURYL | PREGABALINE | 150 mg | Gélule | B/90 | ADWYA | V | N | 22/02/2021 |
42 | HYDRONIL | SULFATE D'HYDROXYCHLOROQUINE | 200 mg | comprimé pelliculé | B/30 | TERIAK | E | N | ___ |
43 | URBANYL | CLOBAZAM | 10 MG | Comprimé sécable | B/30 | SANOFI AVENTIS PHARMA TUNISIE | I | N | 23/02/2021 |
44 | METFORMINE SANOFI | METFORMINE | 850 mg | Comprimé pelliculé | B/30 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 23/02/2021 |
45 | METFORMINE SANOFI | METFORMINE | 1000 MG | Comprimé pelliculé sécable | B/30 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 23/02/2021 |
46 | RODOGYL | METRONIDAZOLE+SPIRAMYCINE | 750 mU/125mg | Comprimé pelliculé | B/20 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 23/02/2021 |
47 | BIRODOGYL | METRONIDAZOLE+SPIRAMYCINE | 1.5 MUI/250 MG | Comprimé pelliculé | B/10 | SANOFI AVENTIS PHARMA TUNISIE | E | N | 23/02/2021 |
48 | ARAVEN IC | IRBESARTAN+AMLODIPINE | 150 mg/5 mg | Comprimé pelliculé | B/28 | PHILADELPHIA PHARMA | E | N | 25/02/2021 |